Gsa Capital Partners LLP Lannett CO Inc Transaction History

Gsa Capital Partners LLP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$0.47 - $0.87 $3,139 - $5,811	-6,680 Reduced 18.38%	29,662 $17,000
Q1 2022 May 11, 2022	BUY	$0.75 - $1.77 $27,256 - $64,325	36,342 New	36,342 $29,000
Q3 2021 Nov 12, 2021	SELL	$2.91 - $4.83 $167,394 - $277,840	-57,524 Closed	0 $0
Q2 2021 Aug 05, 2021	BUY	$4.17 - $5.74 $167,217 - $230,174	40,100 Added 230.14%	57,524 $269,000
Q1 2021 May 10, 2021	BUY	$5.28 - $9.64 $91,998 - $167,967	17,424 New	17,424 $92,000
Q2 2020 Aug 11, 2020	SELL	$6.43 - $9.86 $93,235 - $142,970	-14,500 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$6.36 - $10.05 $305,108 - $482,128	-47,973 Reduced 76.79%	14,500 $101,000
Q4 2019 Feb 12, 2020	BUY	$8.49 - $12.81 $143,557 - $216,604	16,909 Added 37.11%	62,473 $551,000
Q3 2019 Nov 12, 2019	SELL	$5.58 - $14.47 $292,788 - $759,255	-52,471 Reduced 53.52%	45,564 $510,000
Q2 2019 Aug 06, 2019	BUY	$5.22 - $9.08 $511,742 - $890,157	98,035 New	98,035 $594,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.